For example, whether PDGFRβ signaling activates EMT in a tumor cell autonomous manner and whether PDGFRβ-PKCα signaling is required for survival and for maintaining mesenchymal status of the tumor cells in vivo are key unanswered questions that may inform treatment strategies for breast cancer. This evidence concerns the gene PDGFRB and breast cancer.